These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29211892)

  • 1. Evaluation of the effect of live LaSota Newcastle disease virus vaccine as primary immunization on immune development in broilers.
    Martinez JCS; Chou WK; Berghman LR; Carey JB
    Poult Sci; 2018 Feb; 97(2):455-462. PubMed ID: 29211892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
    Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Responses in the Harderian Gland After Newcastle Disease Vaccination in Chickens with Maternal Antibodies.
    Espejo R; Breedlove C; Toro H
    Avian Dis; 2024 Sep; 68(3):192-201. PubMed ID: 39400213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
    Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
    Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype.
    Cornax I; Miller PJ; Afonso CL
    Avian Dis; 2012 Sep; 56(3):464-70. PubMed ID: 23050461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles.
    Zhao K; Chen G; Shi XM; Gao TT; Li W; Zhao Y; Zhang FQ; Wu J; Cui X; Wang YF
    PLoS One; 2012; 7(12):e53314. PubMed ID: 23285276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers.
    Sultan HA; Talaat S; Elfeil WK; Selim K; Kutkat MA; Amer SA; Choi KS
    Poult Sci; 2020 Mar; 99(3):1275-1286. PubMed ID: 32111305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of broilers against Newcastle disease in the presence of maternally derived antibodies.
    Vrdoljak A; Halas M; Süli T
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2017 Jun; 45(3):151-158. PubMed ID: 28480943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different kinetics of chicken interferon-alpha signalling transduction responses following immunization of broiler chickens with different Newcastle disease virus vaccines and infection with virulent genotype VIId strain.
    Hassanin O; Abdallah F; Ali HA; AlGabr N; Mohamed MHA
    Avian Pathol; 2021 Feb; 50(1):85-97. PubMed ID: 33146541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
    Manoharan VK; Varghese BP; Paldurai A; Samal SK
    PLoS One; 2018; 13(5):e0197253. PubMed ID: 29758054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant-attenuated
    Ding K; Shang K; Yu ZH; Yu C; Jia YY; He L; Liao CS; Li J; Zhang CJ; Li YJ; Wu TC; Cheng XC
    J Vet Sci; 2018 Mar; 19(2):232-241. PubMed ID: 29032660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental Infection and Transmission of Newcastle Disease Vaccine Virus in Four Wild Passerines.
    Ayala AJ; Hernandez SM; Olivier TL; Welch CN; Dimitrov KM; Goraichuk IV; Afonso CL; Miller PJ
    Avian Dis; 2019 Sep; 63(3):389-399. PubMed ID: 31967421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stronger Interference of Avian Influenza Virus-Specific Than Newcastle Disease Virus-Specific Maternally Derived Antibodies with a Recombinant NDV-H5 Vaccine.
    Lardinois A; Vandersleyen O; Steensels M; Desloges N; Mast J; van den Berg T; Lambrecht B
    Avian Dis; 2016 May; 60(1 Suppl):191-201. PubMed ID: 27309055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
    Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV.
    Yang HM; Zhao J; Xue J; Yang YL; Zhang GZ
    Vaccine; 2017 Jan; 35(1):27-32. PubMed ID: 27889255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection from clinical disease against three highly virulent strains of Newcastle disease virus after in ovo application of an antibody-antigen complex vaccine in maternal antibody-positive chickens.
    Kapczynski DR; Martin A; Haddad EE; King DJ
    Avian Dis; 2012 Sep; 56(3):555-60. PubMed ID: 23050473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A class Ⅰ lentogenic newcastle disease virus strain confers effective protection against the prevalent strains.
    Li SY; You GJ; Du JT; Xia J; Wen YP; Huang XB; Zhao Q; Han XF; Yan QG; Wu R; Cao SJ; Huang Y
    Biologicals; 2020 Jan; 63():74-80. PubMed ID: 31753578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.